Research
Change Text Size
|

This important study resulted in the June 2009 FDA approval of Ozurdex™, a biodegradable implant which enables the extended release and effect of Dexamethasone, a highly potent corticosteroid. This is used in the treatment of patients with macular...

View study

The safety and efficacy of intravitreal injections of Macugen compared to sham injections in patients with vision loss due to macular edema secondary to Central Retinal Vein Occlusions.

View study